Reverse remodeling with left ventricular assist devices a review of clinical, cellular, and molecular effects

Circulation: Heart Failure

Volumn 4, Issue 2, 2011, Pages 224-233

  Ambardekar, Amrut V ^a   Buttrick, Peter M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Heart failure; Mechanical circulatory support; Mechanical unloading

Indexed keywords

ADRENALIN; ALDOSTERONE ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLENBUTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MICRORNA; NORADRENALIN; RENIN; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BETA ADRENERGIC RECEPTOR; CALCIUM; CYTOKINE; NATRIURETIC FACTOR; SCLEROPROTEIN;

ARTICLE; CALCIUM HOMEOSTASIS; CELL SIZE; CELL STRESS; CONGESTIVE CARDIOMYOPATHY; DEVICE REMOVAL; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; FUNCTIONAL STATUS; GENE EXPRESSION REGULATION; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART OUTPUT; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL TIME; CONVALESCENCE; GENETICS; HEART ASSIST DEVICE; HEART CONTRACTION; HEART VENTRICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROSTHESIS; REVIEW; TREATMENT OUTCOME;

CALCIUM; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDES; NEUROTRANSMITTER AGENTS; PROSTHESIS DESIGN; RECEPTORS, ADRENERGIC, BETA; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79955929563     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.110.959684     Document Type: Article

References (86)

1. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896. (Pubitemid 47347322)
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
3. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361: 2241-2251.
4. Dandel M, Weng Y, Siniawski H, Potapov E, Lehmkuhl HB, Hetzer R. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist device. Circulation. 2005; 112[suppl I]:I-37-I-5.
5. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for reversal of heart failure. N Engl J Med. 2006;355:1873-1884. (Pubitemid 44664645)
6. Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, Miller LW, Margulies K, McRee S, Frazier OH, Torre-Amione G. Cardiac improvement during mechanical circulatory support: A prospective multicenter study of the LVAD working group. Circulation. 2007;115:2497-2505. (Pubitemid 46763223)
7. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609-613.
8. Madigan JD, Barbone A, Choudhri AF, Morales DLS, Cai B, Oz MC, Burkhoff D. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg. 2001;121:902-908.
9. Thohan V, Stetson SJ, Nagueh SF, Rivas-Gotz C, Koerner MM, Lafuente JA, Loebe M, Noon GP, Torre-Amione G. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: A comparative analysis with pulsatile-type devices. J Heart Lung Transplant. 2005;24:566-575. (Pubitemid 40693879)
10. Khan T, Delgado RM, Radovancevic B, Torre-Amione G, Abrams J, Miller K, Myers T, Okerberg K, Stetson SJ, Gregoric I, Hernandez A, Frazier OH. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant. 2003;22:137-146. (Pubitemid 36173670)
11. George RS, Yacoub MH, Tasca G, Webb C, Bowles CT, Tansley P, Hardy JP, Dreyfus G, Khaghani A, Birks EJ. Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: Relevance to assessment of myocardial recovery. J Heart Lung Transplant. 2007;26:967-973. (Pubitemid 47500147)
12. Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, Knosalla C, Hetzer R. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation. 2008:118[suppl 1]:S94-S105.
13. Formica P, Murthy S, Edwards P, Goldstein D, Maybaum S. A structured 3-step approach to evaluate cardiac recovery with continuous flow circulatory support. J Heart Lung Transplant. 2010;29:1440-1442.
14. Kent RL, Uboh CE, Thompson EW, Gordon SS, Marino TA, Hoober JK, Cooper G. Biochemical and structural correlates in unloaded and reloaded cat myocardium. J Mol Cell Cardiol. 1985;17:153-165. (Pubitemid 16241100)
15. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJ, Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med. 1998;4:1269-1275. (Pubitemid 28512107)
16. Razeghi P, Volpini KC, Wang M, Youker KA, Stepkowski S, Taegtmeyer H. Mechanical unloading of the heart activates the calpain system. J Mol Cell Cardiol. 2007;42:449-452. (Pubitemid 46156947)
17. Takaseya T, Ishimatsu M, Tayama E, Nishi A, Akasu T, Aoyagi S. Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy. J Am Coll Cardiol. 2004;44: 2239-2246. (Pubitemid 39576045)
18. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E. Effect of implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995;92[suppl II]: II-191-II-195.
19. Bruggink AH, de Jonge N, van Oosterhout MF, VanWichen DF, de Koning E, Lahpor JR, Kemperman H, Gmeligh-Meyling FH, de Weger RA. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. J Heart Lung Transplant. 2006;25: 174-180. (Pubitemid 43156368)
20. Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, Delgado RM, Frazier OH, Entman ML, Noon GP. Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation. 1999;100:1189-1193. (Pubitemid 29426594)
21. Harding JD, Piacentino V, Gaughan JP, Houser SR, Margulies KB. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation. 2001;104:1241-1247. (Pubitemid 32848112)
22. Terracciano CMN, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation. 2004;109:2263-2265. (Pubitemid 38656863)
23. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998;98:656-662. (Pubitemid 28387492)
24. Baba HA, Grabellus F, August C, Plenz G, Takeda A, Tijan TD, Schmid C, Deng MC. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant. 2000;19:668-674. (Pubitemid 30621679)
25. Barbone A, Holmes JW, Heerdt PM, The AH, Naka Y, Joshi N, Daines M, Marks AR, Oz MC, Burkhoff D. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: A primary role mechanical unloading underlying reverse remodeling. Circulation. 2001;104:670-675. (Pubitemid 32738521)
26. de Jonge N, van Wichen DF, Schipper ME, Lahpor JR, Gmelig-Meyling FH, Robles de Medina EO, de Weger RA. Left ventricular assist device in end-stage heart failure: Persistence of structural myocyte damage after unloading: An immunohistochemical analysis of the contractile myofilaments. J Am Coll Cardiol. 2002;39:963-969. (Pubitemid 34234117)
27. 2+ cycling after left ventricular assist device support in the failing human heart. J Am Coll Cardiol. 2004;44:837-845. (Pubitemid 39099582)
28. Bruckner BA, Razeghi P, Stetson S, Thompson L, Lafuente J, Entman M, Loebe M, Noon G, Taegtmeyer H, Frazier OH, Youker K. Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant. 2004;23:36-42. (Pubitemid 38084828)
29. Schnee PM, Shah N, Bergheim M, Poindexter BJ, Buja LM, Gemmato C, Radovancevic B, Letsou GV, Frazier OH, Bick RJ. Location and density of α- and β-adrenoreceptor sub-types in myocardium after mechanical left ventricular unloading. J Heart Lung Transplant. 2008;27:710-717.
30. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol. 2010;56:382-391.
31. Flesch M, Margulies KB, Mochmann HC, Engel D, Sivasubramanian N, Mann DL. Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation. 2001;104:2273-2276. (Pubitemid 33049507)
32. Baba HA, Stypmann J, Grabellus F, Kirchhof P, Sokoll A, Schafers M, Takeda A, Wilhelm MJ, Scheld HH, Takeda N, Breithardt G, Levkau B. Dynamic regulation of MEK/Erks and Akt/GSK-3β in human end-stage heart failure after left ventricular mechanical support: Myocardial mechanotransduction- sensitivity as a possible molecular mechanism. Cardiovasc Res. 2003;59:390-399. (Pubitemid 37272033)
33. Razeghi P, Buksinska-Lisik M, Palanichamy N, Stepkowski S, Frazier OH, Taegtmeyer H. Transcriptional regulators of ribosomal biogenesis are increased in the unloaded heart. FASEB J. 2006;20:1090-1096. (Pubitemid 44943905)
34. Barton PJR, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation. 2005; 112[suppl I]:I-46-I-50. (Pubitemid 41266652)
35. Kinoshita M, Takano H, Takaichi S, Taenaka Y, Nakatani T. Influence of prolonged ventricular assistance on myocardial histopathology in intact heart. Ann Thorac Surg. 1996;61:640-645. (Pubitemid 26060894)
36. Sharma S, Ying J, Razeghi P, Stepkowski S, Taegtmeyer H. Atrophic remodeling of the transplanted rat heart. Cardiology. 2006;105:128-136. (Pubitemid 43189789)
37. Brinks H, Tevaearai H, Muhlfeld C, Bertschi D, Gahl B, Carrel T, Giraud MN. Contractile function is preserved in unloaded hearts despite atrophic remodeling. J Thorac Cardiovasc Surg. 2009;137:742-746.
38. Oriyanhan W, Tsuneyoshi H, Nishina T, Matsuoka S, Ikeda T, Komeda M. Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotropic heart transplantation model. J Heart Lung Transplant. 2007;26:16-23. (Pubitemid 46096745)
39. Rose AG, Park SJ. Pathology in patients with ventricular assist devices: A study of 21 autopsies, 24 ventricular apical core biopsies and 24 explanted hearts. Cardiovasc Pathol. 2005;14:19-23. (Pubitemid 40248428)
40. Wohlschlaeger J, Levkau B, Brockhoff G, Schmitz KJ, von Winterfeld M, Takeda A, Takeda N, Stypmann J, Vahlhaus C, Schmid C, Pomjanski N, Bocking A, Baba HA. Hemodynamic support by left ventricular assist device reduces cardiomyocyte DNA content in the failing human heart. Circulation. 2010;121:989-996.
41. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998;97:2316-2322. (Pubitemid 28280385)
42. Noguchi T, Hunlich M, Camp PC, Begin KJ, El-Zaru M, Patten R, Leavitt BJ, Ittleman FP, Alpert NR, LeWinter MM, VanBuren P. Thin filament-based modulation of contractile performance in human heart failure. Circulation. 2004;110:982-987. (Pubitemid 39136215)
43. Ogletree-Hughes ML, Stull LB, Sweet WE, Smedira NG, McCarthy PM, Moravec CS. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation. 2001;104:881-886. (Pubitemid 32778037)
44. Klotz S, Barbone A, Reiken S, Holmes JW, Naka Y, Oz MC, Marks AR, Burkhoff D. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol. 2005;45:668-676. (Pubitemid 40278964)
45. Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 2000;102:2713-2719.
46. Perrino C, Schroder JN, Lima B, Villamizar N, Nienaber JJ, Milano CA, Naga Prasad SV. Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure. Circulation. 2007;116:2571-2579.
47. Bick RJ, Grigore AM, Poindexter BJ, Schnee PM, Nussmeier NA, Gregoric ID, Shah NA, Myers TJ, Buja LM, Frazier OH. Left ventricular unloading with an assist device results in receptor relocalization as well as increased beta-adrenergic receptor numbers: Are these changes indications for outcome? J Card Surg. 2005;20:332-336. (Pubitemid 40992552)
48. Milting H, Scholz C, Arusoglu L, Freitag M, Cebullar R, Jaquet K, Korfer R, V Lewinski D, Kassner A, Brodde OE, Kogler H, El Banayosy A, Pieske B. Selective upregulation of β1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. J Mol Cell Cardiol. 2006;41:441-450. (Pubitemid 44344275)
49. Pandalai PK, Bulcao CF, Merrill WH, Akhter SA. Restoration of myocardial β-adrenergic receptor signaling after left ventricular assist device support. J Thorac Cardiovasc Surg. 2006;131:975-980.
50. Terracciano CMN, Harding SE, Adamson D, Koban M, Tansley P, Birks EJ, Barton PJ, Yacoub MH. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur Heart J. 2003;24:1329-1339. (Pubitemid 36917704)
51. 2+ exchanger in reverse remodeling: Relevance for LVAD-recovery. Ann N Y Acad Sci. 2007; 1099:349-360. (Pubitemid 47092624)
52. 2+ cycling proteins and Gαq signaling after left ventricular assist device support in failing human hearts. Cardiovasc Res. 2000;45:883-888. (Pubitemid 30089650)
53. Ogletree ML, Sweet WE, Talerico C, Klecka ME, Young JB, Smedira NG, Starling RC, Moravec CS. Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing heart. J Heart Lung Transplant. 2010;29:554-561.
54. Marx SO, Reiken S, Hisamatsu Y. Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell. 2000;101:365-376.
55. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanic assist devices. Circ Res. 2002;91:517-524.
56. 2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation. Am J Physiol Heart Circ Physiol. 2008;294:H2257-H2267.
57. Latif N, Yacoub MH, George R, Barton PJR, Birks EJ. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant. 2007;26:230-235. (Pubitemid 46341890)
58. Schwoerer AP, Neuber C, Schmechel A, Melnychenko I, Mearini G, Boknik P, Kirchhefer U, Schmitz W, Ehmke H, Eschenhagen T, El-Armouche A. Mechanical unloading of the rat heart involves marked changes in the protein kinase-phosphatase balance. J Mol Cell Cardiol. 2008;45:846-852.
59. Bruckner BA, Stetson SJ, Farmer JA, Radovancevic B, Frazier OH, Noon GP, Entman ML, Torre-Amione G, Youker KA. The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg. 2000;180:498-501.
60. Bruckner BA, Stetson SJ, Perez-Verdia A, Youker KA, Radovancevic B, Connelly JH, Koerner MM, Entman ME, Frazier OH, Noon GP, Torre- Amione G. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant. 2001;20:457-464. (Pubitemid 32297756)
61. Klotz S, Foronjy RF, Dickstein ML, Gu A, Garrelds IM, Danser AH, Oz MC, D'Armiento J, Burkhoff D. Mechanical unloading during left ventricular assist device support increases left ventricular collagen crosslinking and myocardial stiffness. Circulation. 2005;112:364-374. (Pubitemid 41022077)
62. Li YY, Feng Y, McTiernan CF, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, Feldman AM. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. 2001;104: 1147-1152. (Pubitemid 32830399)
63. Bruggink AH, van Oosterhout MF, de Jonge N, Cleutjens JP, van Wichen DF, van Kuik J, Tilanus MG, Gmelig-Meyling FH, van den Tweel JG, de Weger RA. Type IV collagen degradation in the myocardial basement membrane after unloading of the failing heart by a left ventricular assist device. Laboratory Invest. 2007;87:1125-1137. (Pubitemid 47609022)
64. Klotz S, Danser AHJ, Foronjy RF, Oz MC, Wang J, Mancini D, D'Armiento J, Burkhoff D. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol. 2007;49:1166-1174. (Pubitemid 46400328)
65. Bruggink AH, van Oosterhout MF, de Jonge N, Ivangh B, van Kuik J, Voorbij RH, Cleutjens JP, Gmelig-Meyling FH, de Weger RA. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant. 2006;25:1091-1098. (Pubitemid 44311529)
66. Aquila LA, McCarthy PM, Smedira NG, Young JB, Moravec CS. Cytoskeletal structure and recovery in single human myocytes. J Heart Lung Transplant. 2004;23:954-963. (Pubitemid 39108106)
67. Vatta M, Stetson SJ, Perez-Verdia A, Entman ML, Noon GP, Torre- Amione G, Bowles NE, Towbin JA. Molecular remodeling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet. 2002;359:936-941. (Pubitemid 34246384)
68. Vatta M, Stetson SJ, Jimenez S, Entman ML, Noon GP, Bowles NE, Towbin JA, Torre-Amione G. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol. 2004;43:811-817. (Pubitemid 38296481)
69. Lee SH, Doliba N, Osbakken M, Oz M, Mancini D. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. J Thorac Cardiovasc Surg. 1998;116:344-349. (Pubitemid 28367103)
70. Mital S, Loke KE, Addonizio LJ, Oz MC, Hintze TH. Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts. J Am Coll Cardiol. 2000;36:1897-1902.
71. Grabellus F, Schmid C, Levkau B, Breukelmann D, Halloran PF, August C, Takeda N, Takeda A, Wilhelm M, Deng MC, Baba HA. Reduction of hypoxia-inducible heme oxygenase-1 in the myocardium after left ventricular mechanical support. J Pathol. 2002;197:230-237. (Pubitemid 34567611)
72. Kassiotis C, Ballal K, Wellnitz K, Vela D, Gong M, Salazar R, Frazier OH, Taegtmeyer H. Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation. 2009;120[suppl]: S191-S197.
73. Francis GS, Anwar F, Bank AJ, Kubo SH, Jessurun J. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: Observations made after implantation of left ventricular assist device. J Card Fail. 1999;5:308-315. (Pubitemid 30033672)
74. Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol. 2003;41:1096-1106. (Pubitemid 36384894)
75. Bartling B, Milting H, Schumann H, Darmer D, Arusoglu L, Koerner MM, El-Banayosy A, Koerfer R, Holtz J, Zerkowski HR. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation. 1999;100[suppl II]: II-216 -II-223. (Pubitemid 29523538)
76. Morawietz H, Szibor M, Goettsch W, Bartling B, Barton M, Shaw S, Koerfer R, Zerkowski HR, Holtz J. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ETA receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation. 2000;102[suppl III]:III-188 -III-193.
77. Razeghi P, Young ME, Ying J, Depre C, Uray IP, Kolesar J, Shipley GL, Moravec CS, Davies PJ, Frazier OH, Taegtmeyer H. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology. 2002;97:203-309.
78. Razeghi P, Bruckner BA, Sharma S, Youker KA, Frazier OH, Taegtmeyer H. Mechanical unloading of the failing human heart fails to activate the protein kinase B/Akt/Glycogen synthase kinase-3β survival pathway. Cardiology. 2003;100:17-22. (Pubitemid 37140414)
79. Birks EJ, Hall JL, Barton PJ, Grindle S, Latif N, Hardy JP, Rider JE, Banner NR, Khaghani A, Miller LW, Yacoub MH. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular- assist device support. Circulation. 2005;112[suppl I]:I-57-I-64. (Pubitemid 41266654)
80. Rodrigue-way A, Burkhoff D, Geesaman BJ, Golden S, Xu J, Pollman MJ, Donoghue M, Jeyaseelan R, Houser S, Breitbart RE, Marks A, Acton S. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant. 2005;24: 73-80. (Pubitemid 40093996)
81. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW, Birks EJ, Yacoub MH, Barton PJ. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: Potential implications for local creatine synthesis. Circulation. 2006;114[suppl]:I-16 -I-20. (Pubitemid 44297122)
82. Hall JL, Birks EJ, Grindle S, Cullen ME, Barton PJ, Rider JE, Lee S, Harwalker S, Mariash A, Adhikari N, Charles NJ, Felkin LE, Polster S, George RS, Miller LW, Yacoub MH. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J. 2007;28:613-627. (Pubitemid 47355497)
83. Lowes BD, Zolty R, Shakar SF, Brieke A, Gray N, Reed M, Calalb M, Minobe W, Lindenfeld J, Wolfel EE, Geraci M, Bristow MR, Cleveland J. Assist devices fail to reverse patterns of fetal gene expression despite β-blockers. J Heart Lung Transplant. 2007;26:1170-1176. (Pubitemid 350088515)
84. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, Bednarik D. Mixed messages: Transcription patterns in failing and recovering human myocardium. Circ Res. 2005;96:592-599. (Pubitemid 40463469)
85. Schipper MEI, van Kuik J, de Jonge N, Dullens HFJ, de Weger RA. Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support. J Heart Lung Transplant. 2008;27:1282-1285.
86. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation. 2009;119:1263-1271.